Terms: = Breast cancer AND EPS15, AF-1P, 2060, ENSG00000085832, P42566, MLLT5, AF1P AND Treatment
26 results:
1. Severe hyponatremia and diabetes insipidus caused by low-dose cyclophosphamide in breast cancer patients: A case report and literature review.
Chen Y; Li L; Ou R; Wu Y; Pan B; Luo L
Medicine (Baltimore); 2024 Mar; 103(13):e37572. PubMed ID: 38552085
[TBL] [Abstract] [Full Text] [Related]
2. Assessing the relationship between tumor-infiltrating lymphocytes and PD-L1 expression in triple negative breast cancer: Identifying optimal TILs cut-off value for pathologic reporting.
Suwannaphoom K; Soontornsit S; Wiwatwarayos K; Seneetuntigul P; Julimasart P
Ann Diagn Pathol; 2024 Jun; 70():152294. PubMed ID: 38513466
[TBL] [Abstract] [Full Text] [Related]
3. Aromatase Inhibitor Musculoskeletal Syndrome and Bone Loss: a Review of the Current Literature.
Christensen Holz S
Curr Oncol Rep; 2023 Jul; 25(7):825-831. PubMed ID: 37052869
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance of lung metastasis-related finding in lenvatinib treatment for differentiated thyroid cancer.
Yamazaki H; Iwasaki H; Masudo K; Toda S; Matsui A; Rino Y
Endocrine; 2022 Dec; 78(3):543-551. PubMed ID: 36070050
[TBL] [Abstract] [Full Text] [Related]
5. Prospective clinical trial on the learning curve of high-intensity-focused ultrasound for the treatment of breast fibroadenoma.
Co M; Chen C; Lee C; Yu S; Kwong A
Surg Today; 2022 Jul; 52(7):1048-1053. PubMed ID: 35000002
[TBL] [Abstract] [Full Text] [Related]
6. Karate as a supporting therapy of secondary prevention in breast cancer: a pilot study.
Lindemann U; Buhl M; Nacke A
J Sports Med Phys Fitness; 2021 Nov; 61(11):1523-1528. PubMed ID: 33480512
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy and safety evaluation of eribulin-trastuzumab combination therapy with heavily pretreated HER2-positive metastatic breast cancer.
Sarici F; Altundag K
J BUON; 2020; 25(6):2562-2569. PubMed ID: 33455097
[TBL] [Abstract] [Full Text] [Related]
8. Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade.
Brasó-Maristany F; Griguolo G; Pascual T; Paré L; Nuciforo P; Llombart-Cussac A; Bermejo B; Oliveira M; Morales S; Martínez N; Vidal M; Adamo B; Martínez O; Pernas S; López R; Muñoz M; Chic N; Galván P; Garau I; Manso L; Alarcón J; Martínez E; Gregorio S; Gomis RR; Villagrasa P; Cortés J; Ciruelos E; Prat A
Nat Commun; 2020 Jan; 11(1):385. PubMed ID: 31959756
[TBL] [Abstract] [Full Text] [Related]
9. Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literature.
Banys-Paluchowski M; Gruber IV; Hartkopf A; Paluchowski P; Krawczyk N; Marx M; Brucker S; Hahn M
Arch Gynecol Obstet; 2020 Feb; 301(2):341-353. PubMed ID: 31897672
[TBL] [Abstract] [Full Text] [Related]
10. Determinants of breast self-examination practice among women in Surabaya, Indonesia: an application of the health belief model.
Dewi TK; Massar K; Ruiter RAC; Leonardi T
BMC Public Health; 2019 Nov; 19(1):1581. PubMed ID: 31775697
[TBL] [Abstract] [Full Text] [Related]
11. Antrodia camphorata inhibits epithelial-to-mesenchymal transition by targeting multiple pathways in triple-negative breast cancers.
Hseu YC; Chang GR; Pan JY; Rajendran P; Mathew DC; Li ML; Liao JW; Chen WT; Yang HL
J Cell Physiol; 2019 Apr; 234(4):4125-4139. PubMed ID: 30146779
[TBL] [Abstract] [Full Text] [Related]
12. [A Case of a Corneal Disorder after breast cancer treatment with Nab-paclitaxel].
Hosotani Y; Morimatsu T; Takata M; Mimura O
Nippon Ganka Gakkai Zasshi; 2016 Jun; 120(6):449-53. PubMed ID: 27487717
[TBL] [Abstract] [Full Text] [Related]
13. Comparative analysis of tumor spheroid generation techniques for differential in vitro drug toxicity.
Raghavan S; Mehta P; Horst EN; Ward MR; Rowley KR; Mehta G
Oncotarget; 2016 Mar; 7(13):16948-61. PubMed ID: 26918944
[TBL] [Abstract] [Full Text] [Related]
14. Endpoint comparison for bone mineral density measurements in North Central cancer treatment Group cancer clinical trials N02C1 and N03CC (Alliance).
Dueck AC; Singh J; Atherton P; Liu H; Novotny P; Hines S; Loprinzi CL; Perez EA; Tan A; Burger K; Zhao X; Diekmann B; Sloan JA;
Osteoporos Int; 2015 Jul; 26(7):1971-7. PubMed ID: 25749740
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of digital infra-red thermal imaging as an adjunctive screening method for breast carcinoma: a pilot study.
Rassiwala M; Mathur P; Mathur R; Farid K; Shukla S; Gupta PK; Jain B
Int J Surg; 2014 Dec; 12(12):1439-43. PubMed ID: 25448668
[TBL] [Abstract] [Full Text] [Related]
16. UIM domain-dependent recruitment of the endocytic adaptor protein eps15 to ubiquitin-enriched endosomes.
Gucwa AL; Brown DA
BMC Cell Biol; 2014 Sep; 15():34. PubMed ID: 25260758
[TBL] [Abstract] [Full Text] [Related]
17. Retinal metastasis from systemic cancer in 8 cases.
Shields CL; McMahon JF; Atalay HT; Hasanreisoglu M; Shields JA
JAMA Ophthalmol; 2014 Nov; 132(11):1303-8. PubMed ID: 25033168
[TBL] [Abstract] [Full Text] [Related]
18. Examining and predicting drug preferences of patients with metastatic breast cancer: using conjoint analysis to examine attributes of paclitaxel and capecitabine.
Smith ML; White CB; Railey E; Sledge GW
Breast Cancer Res Treat; 2014 May; 145(1):83-9. PubMed ID: 24647891
[TBL] [Abstract] [Full Text] [Related]
19. Women's experience of acute and chronic pain following breast cancer surgery.
Hovind IL; Bredal IS; Dihle A
J Clin Nurs; 2013 Apr; 22(7-8):1044-52. PubMed ID: 23480500
[TBL] [Abstract] [Full Text] [Related]
20. Cdk2 silencing via a DNA/PCL electrospun scaffold suppresses proliferation and increases death of breast cancer cells.
Achille C; Sundaresh S; Chu B; Hadjiargyrou M
PLoS One; 2012; 7(12):e52356. PubMed ID: 23285007
[TBL] [Abstract] [Full Text] [Related]
[Next]
